Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 09, 2019; 92 (15 Supplement) May 6, 2019

Visual contrast threshold at 15 Hz is able to confirm visual snow syndrome in individual patients (S20.005)

Ozan Eren, Thomas Eggert, Ruth Ruscheweyh, Andreas Straube, Christoph Schankin
First published April 16, 2019,
Ozan Eren
1Department of Neurology, LMU Munich, University Hospital - Großhadern Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Eggert
1Department of Neurology, LMU Munich, University Hospital - Großhadern Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Ruscheweyh
1Department of Neurology, LMU Munich, University Hospital - Großhadern Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Straube
1Department of Neurology, LMU Munich, University Hospital - Großhadern Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Schankin
1Department of Neurology, LMU Munich, University Hospital - Großhadern Munich Germany
2Department of Neurology, Inselspital, Bern University Hospital, University of Bern Bern Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Visual contrast threshold at 15 Hz is able to confirm visual snow syndrome in individual patients (S20.005)
Ozan Eren, Thomas Eggert, Ruth Ruscheweyh, Andreas Straube, Christoph Schankin
Neurology Apr 2019, 92 (15 Supplement) S20.005;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To confirm the presence of visual snow syndrome (VS) in the individual patient. We tested the hypothesis that patients with VS have an increased threshold for detecting visual contrasts.

Background: Patients with VS suffer from a continuous TV snow-like visual disturbance in the entire visual field that might reduce the contrast perceived. Currently, the only objective measure is hypermetabolism of the lingual gyrus found at the group level. In clinical practice, however, individual patients present with subjective symptoms, and objective measures are lacking to confirm the diagnosis.

Design/Methods: Twenty patients with VS were compared to 20 age-, gender-, migraine- and aura-matched controls. Subjects were randomly presented vertically left or right tilted bars flickering at six different frequencies (15Hz, 20Hz, 25Hz, 30Hz, 35Hz, 40Hz). The contrast threshold was measured in a two-alternative adaptive forced-choice procedure (QUEST) for the discrimination between the two image orientations. The threshold was defined as the log10 (Michelson-Contrast) necessary to achieve the correct response in 75% of the cases.

Results: The 75% contrast threshold at 15 Hz was significantly higher in VS patients compared to controls (0.601 Wilks-Lambda p=0.007; −1.94±0.13 vs. −2.26±0.37, T=−3.71, p=0.001, MANOVA). The AUC for the ROC curve of 75% contrast threshold at 15 Hz was 0.73±0.09. A contrast threshold of −2,00 is able to support the diagnosis of VS in an individual patient with a sensitivity of 80% and a specificity of 70%.

Conclusions: The visual 75% contrast threshold measured at 15 Hz is the first technical test that might be able to confirm the hitherto purely subjective and history-driven diagnosis of VS in an individual patient.

Disclosure: Dr. Eren has nothing to disclose. Dr. Eggert has nothing to disclose. Dr. Ruscheweyh has nothing to disclose. Dr. Straube has nothing to disclose. Dr. Schankin has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Pharmaceuticals, Almirall, Eli Lilly, and Allergan.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (4)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise